CNTF, an anti-obesity, anti-diabetogenic cytokine [16, 18, 48–50], promotes the same effects in mice: reduced IDE expression in the liver, reduced insulin clearance, and improved insulin sensitivity through IR-AKT phosphorylation. The gene discussed is AKT1; the disease is obesity disorder.